Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Exchange Rate Effect (2016 - 2018)

Historic Exchange Rate Effect for Altimmune (ALT) over the last 10 years, with Q2 2018 value amounting to -$48470.0.

  • Altimmune's Exchange Rate Effect fell 20977.49% to -$48470.0 in Q2 2018 from the same period last year, while for Dec 2018 it was -$50365.0, marking a year-over-year decrease of 16770.67%. This contributed to the annual value of -$50365.0 for FY2018, which is 16770.67% down from last year.
  • Altimmune's Exchange Rate Effect amounted to -$48470.0 in Q2 2018, which was down 20977.49% from -$1895.0 recorded in Q1 2018.
  • Altimmune's Exchange Rate Effect's 5-year high stood at $44154.0 during Q2 2017, with a 5-year trough of -$98830.0 in Q2 2016.
  • Moreover, its 5-year median value for Exchange Rate Effect was -$1696.0 (2016), whereas its average is -$9007.7.
  • Per our database at Business Quant, Altimmune's Exchange Rate Effect skyrocketed by 243612.17% in 2015 and then plummeted by 1378214.29% in 2016.
  • Altimmune's Exchange Rate Effect (Quarter) stood at -$5256.0 in 2014, then surged by 63.01% to -$1944.0 in 2015, then increased by 22.99% to -$1497.0 in 2016, then crashed by 734.47% to -$12492.0 in 2017, then plummeted by 288.01% to -$48470.0 in 2018.
  • Its Exchange Rate Effect stands at -$48470.0 for Q2 2018, versus -$1895.0 for Q1 2018 and -$12492.0 for Q4 2017.